Company Filing History:
Years Active: 2017
Title: Tsung-Lin Cheng: Innovator in Bone Loss Treatment
Introduction
Tsung-Lin Cheng is a prominent inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of medical science, particularly in the treatment of bone loss diseases. His innovative approach has led to the development of a unique therapeutic method that addresses a critical health issue.
Latest Patents
Tsung-Lin Cheng holds 1 patent for his invention related to the TMD1 protein. This patent describes a method for treating bone loss diseases, conditions, or disorders in subjects in need. The method involves administering a pharmaceutically effective amount of a composition that includes thrombomodulin lectin-like domain (TMD1).
Career Highlights
Cheng is affiliated with Kaohsiung Medical University, where he continues to engage in research and development. His work focuses on advancing medical treatments and improving patient outcomes in the field of bone health.
Collaborations
He has collaborated with notable colleagues, including Jwu-Lai Yeh and Mei-Ling Ho, to further enhance the impact of his research and innovations.
Conclusion
Tsung-Lin Cheng's contributions to the treatment of bone loss diseases exemplify the importance of innovation in medical science. His work not only highlights his expertise but also underscores the potential for advancements in healthcare through dedicated research and collaboration.